Search research articles
Contact Us
Filters
Showing results (181-190 of 255) with videos related to
Page
of 26
Sort By:
British Journal of Haematology
|
February 23, 2018
Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units
Vera A de Vries, Marcella C A Müller, M Sesmu Arbous, et al.
Experimental Hematology
|
June 23, 2009
Elevated endothelial progenitor cells during painful sickle cell crisis
Rachel T van Beem, Erfan Nur, Jaap Jan Zwaginga, et al.
Critical Care Medicine
|
October 19, 2018
Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care
Vera A de Vries, Marcella C A Müller, M Sesmu Arbous, et al.
Critical Care Explorations
|
May 30, 2024
Development and Validation of a Prediction Model for 1-Year Mortality in Patients With a Hematologic Malignancy Admitted to the ICU
Jan-Willem H L Boldingh, M Sesmu Arbous, Bart J Biemond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 2024
Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India)
Harjeet S Virk, Jason J Biemond, Venkat A Earny, et al.
Chest
|
January 17, 2008
Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension
Eduard J van Beers, Berthe L F van Eck-Smit, Melvin R Mac Gillavry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories
Jan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
European Journal of Haematology
|
December 27, 2024
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Man Wai Tang, Deborah Van der Tuin, Mesire Aydin, et al.
The New England Journal of Medicine
|
March 18, 2011
Cytarabine dose for acute myeloid leukemia
Bob Löwenberg, Thomas Pabst, Edo Vellenga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2013
Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)
Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 255) with videos related to
Sort By:
Page
of 26
British Journal of Haematology
|
February 23, 2018
Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units
Vera A de Vries, Marcella C A Müller, M Sesmu Arbous, et al.
Experimental Hematology
|
June 23, 2009
Elevated endothelial progenitor cells during painful sickle cell crisis
Rachel T van Beem, Erfan Nur, Jaap Jan Zwaginga, et al.
Critical Care Medicine
|
October 19, 2018
Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care
Vera A de Vries, Marcella C A Müller, M Sesmu Arbous, et al.
Critical Care Explorations
|
May 30, 2024
Development and Validation of a Prediction Model for 1-Year Mortality in Patients With a Hematologic Malignancy Admitted to the ICU
Jan-Willem H L Boldingh, M Sesmu Arbous, Bart J Biemond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 2024
Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India)
Harjeet S Virk, Jason J Biemond, Venkat A Earny, et al.
Chest
|
January 17, 2008
Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension
Eduard J van Beers, Berthe L F van Eck-Smit, Melvin R Mac Gillavry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories
Jan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
European Journal of Haematology
|
December 27, 2024
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Man Wai Tang, Deborah Van der Tuin, Mesire Aydin, et al.
The New England Journal of Medicine
|
March 18, 2011
Cytarabine dose for acute myeloid leukemia
Bob Löwenberg, Thomas Pabst, Edo Vellenga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2013
Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)
Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, et al.
Page
of 26